蜂胶酊对小鼠大肠埃希菌阴道炎疗效观察

目的探讨蜂胶酊对小鼠阴道内致病菌抑制及调理阴道菌群的作用。方法通过感染大肠埃希菌建立小鼠阴道炎模型,用10％和20％蜂胶酊冲洗治疗去除大肠埃希菌在小鼠阴道的定植。倾注培养（37℃,48h）计数阴道分泌物的细菌总数,镜下观察阴道黏膜炎症程度。结果蜂胶酊治疗组小鼠阴道内细菌的数量明显较对照组的数量减少（P〈0．05）,治疗组黏膜炎症的治愈程度显著好于对照组。结论蜂胶酊对小鼠大肠埃希菌性阴道炎有较好的治疗效果。     

乳杆菌DM8909菌株抑制小鼠阴道感染的研究

目的 :探讨乳杆菌 DM880 9菌株对小鼠阴道内其他菌群的抑制及调整阴道菌群的作用。方法 :通过用阿莫西林钠溶液对小鼠阴道冲洗处理后 ,接种致病性大肠埃希菌 EPEC10 4 ,建立起大肠埃希菌在小鼠阴道内的定植 ;用乳杆菌 DM890 9菌液冲洗治疗来去除大肠埃希菌 EPEC10 4在小鼠阴道的定植。结果 :通过各组小鼠阴道冲洗液检出的平均对数值比较 ,乳杆菌治疗组的小鼠阴道内大肠埃希菌的数量 ( 3.82±0 .6 2 )较自然恢复组小鼠阴道内大肠埃希菌的数量 ( 6 .72± 1.16 )减少明显 ( P<0 .0 5 ) ,而且治疗组的症状好转率 ( 8/10 )显著好于自然恢复组的症状好转率 ( 2 /10 ) ( P<0 .0 5 )。结论 :乳杆菌 DM890 9菌株能有效去除大肠埃希菌 EPEC10 4在小鼠阴道的定植和改善小鼠外阴的炎症症状     

蜂胶酊对金黄色葡萄球菌性阴道炎疗效观察

目的探讨蜂胶酊对小鼠阴道内致病菌抑制及调理阴道菌群的作用。方法通过感染金黄色葡萄球菌建立小鼠阴道炎模型,用10％蜂胶酊冲洗治疗去除金黄色葡萄球菌在小鼠阴道的定植。倾注培养法（37℃,48h）计数阴道分泌物的细菌总数,镜下观察阴道黏膜炎症程度。结果蜂胶酊治疗组小鼠阴道内细菌的数量明显较对照组数量减少（P〈0．05）,治疗组黏膜炎症的治愈程度显著好于对照组。结论蜂胶酊对小鼠金黄色葡萄球菌性阴道炎有较好的治疗效果。     

乳酸杆菌代谢产物对一些常见菌黏附阴道上皮细胞的抑制作用的初步探讨

目的 探讨乳酸杆菌代谢产物对大肠埃希菌、铜绿假单胞菌、金黄色葡萄球菌和白色念珠菌黏附阴道上皮细胞的抑制作用.方法 刮取健康妇女阴道上皮细胞进行体外培养,观察在乳酸杆菌代谢产物的干预下大肠埃希菌、铜绿假单胞菌、金黄色葡萄球菌和白色念珠菌黏附阴道上皮细胞的情况.结果 和结论 乳酸杆菌代谢产物能够明显抑制大肠埃希菌、铜绿假单胞菌、金黄色葡萄球菌和白色念珠菌对阴道上皮细胞的黏附.     

乳酸杆菌细胞裂解物对家兔实验性阴道炎的治疗作用

目的观察乳杆菌DM8909裂解物及发酵物在体内对大肠埃希菌、金黄色葡萄球菌的抑制效果,探索一种替代活菌制剂的生态制剂。方法用阿莫西林和甲硝唑接种家兔建立脱污染模型,再用大肠埃希菌和金黄色葡萄球菌的混合液接种,建立实验性感染模型后,随机分为5组,分别用乳杆菌裂解物原液、裂解物稀释液、发酵上清液、乳杆菌活菌制剂及生理盐水(对照组)进行治疗,分析和考察阴道菌群变化。结果德氏乳酸杆菌裂解物具有治疗实验性家兔细菌性阴道炎的效果,其疗效与活菌制剂相近。结论德氏乳酸杆菌裂解物可作为乳酸杆菌活菌制剂的替代物。     

地衣芽胞杆菌对实验性家兔阴道炎影响的研究

目的通过探讨地衣芽胞杆菌活菌制剂对实验性家兔细菌性阴道病的影响,恢复家兔阴道微生态平衡和正常菌群环境。方法（1）采用注射用氨苄西林和甲硝唑生理盐水溶液注入家兔阴道进行冲洗,建立家兔阴道脱污染动物模型。（2）取40只阴道脱污染家兔,其中20只接种大肠埃希菌,20只接种金黄色葡萄球菌,建立家兔阴道感染模型。（3）地衣芽胞杆菌对家兔阴道菌群失调的调整作用：采用不同浓度的地衣芽胞杆菌菌液（10^6CFU／ml、10^8CFU／ml、10^9CFU／ml）对感染家免阴道进行接种,分析和考察地衣芽胞杆菌对家兔阴道菌群失调的影响以及对家兔阴道黏膜的影响。结果（1）动物经过金黄色葡萄球菌感染,通过地衣芽胞杆菌治疗后,动物阴道内芽胞杆菌、肠杆菌、乳杆菌数量明显上升,葡萄球菌数量明显下降,自细胞数量减少,黏膜红肿减轻、分泌物减少,治疗作用明显。（2）大肠埃希菌感染动物经地衣芽胞杆菌治疗后,动物阴道内芽胞杆菌、乳杆菌数量明显上升,肠杆菌数量明显降低,白细胞数量减少,黏膜红肿消失、分泌物减少。结论地衣芽胞杆菌对实验性家兔金黄色葡萄球菌和大肠埃希菌阴道炎的治疗有效。地衣芽胞杆菌与乳杆菌的作用相似,具有维持阴道菌群平衡的作用。     

大肠埃希菌性阴道感染小鼠模型的建立

目的 :建立大肠埃希菌定植的阴道感染小鼠模型。方法 :在阿莫西林溶液 (12 5mg/ml)冲洗小鼠阴道冲洗处理下 ,将致病性大肠埃希菌接种到小鼠阴道内。结果 :各组小鼠阴道冲洗液检出的平均对数值比较 ,经过阿莫西林溶液小鼠阴道冲洗处理后再接种大肠埃希菌的阿莫西林 +大肠埃希菌组 ,阴道内定植的大肠埃希菌数量 (8 18± 1 0 9)较经过生理盐水小鼠阴道冲洗处理后再接种大肠埃希菌组 (5 72± 0 6 8)明显增多 (P <0 0 5 ) ,而且小鼠阴道感染的症状明显 (P <0 0 5 )。结论 :通过抗生素处理后 ,再在小鼠阴道内接种大肠埃希菌 ,大肠埃希菌能够在小鼠阴道内得到定植 ,即建立起大肠埃希菌性阴道感染的小鼠模型。     

乳酸杆菌代谢产物对引起阴道炎常见细菌的抑制作用的初步探讨

目的探讨乳酸杆菌代谢产物对临床常见引起阴道炎的大肠埃希菌、铜绿假单胞菌、金黄色葡萄球菌、白色念珠菌、伤寒杆菌和肠球菌的抑菌作用。方法采用营养琼脂平板培养基定量涂菌,国际标准药敏杯给药的药敏试验法,检测乳酸杆菌代谢产物对大肠埃希菌、铜绿假单胞菌、金黄色葡萄球菌、白色念珠菌、伤寒杆菌和肠球菌的抑菌环的大小。结果乳酸杆菌代谢产物对大肠埃希菌、铜绿假单胞菌、金黄色葡萄球菌和伤寒杆菌有明显的抑菌作用,对肠球菌、白色念珠菌无抑菌作用。结论在临床上可应用乳酸杆菌及其制剂调节阴道微生态平衡,治疗细菌性阴道炎。     

益气健脾中药颗粒剂对早期断奶仔猪肠道菌群的影响

目的研究中药复方颗粒剂对断奶仔猪肠道微生态的影响。方法实验选用人工感染大肠埃希菌引起腹泻的28日龄断奶仔猪54头,随机平均分为3组,每组3个重复,Ⅰ组抗生素治疗组、Ⅱ组中药复方颗粒剂治疗组、Ⅲ组不用任何药物治疗的空白对照组。分别于用药后第14天时,每组随机抽取1头屠宰,无菌采集空肠,回肠和盲肠内容物,利用平板计数法测定各肠段大肠埃希菌、双歧杆菌和乳酸杆菌数量。结果 Ⅰ组双歧杆菌、乳酸杆菌及大肠埃希菌的数量均显著小于Ⅲ组（P〈0.05）;Ⅱ组双歧杆菌和乳酸杆菌的数量显著大于Ⅲ组（P〈0.05）,大肠埃希菌数量显著小于Ⅲ组（P〈0.05）; n组双歧杆菌和乳酸杆菌的数量极显著大于Ⅰ组（P〈0.01）,Ⅱ组与Ⅰ组大肠埃希菌数量差异无统计学意义（P〉0.05）。结论该中药复方颗粒剂具有显著增加断奶仔猪肠道中双歧杆菌和乳酸杆菌的数量,降低大肠埃希菌数量,减少腹泻频率的作用。     

抗菌药物对金双歧去除定植于肠道产ESBLs大肠埃希菌效果的影响研究

目的研究抗菌药物对金双歧去除肠道产ESBLs大肠埃希菌定植效果的影响,为临床合理利用金双歧辅助治疗提供依据。方法选取崇州市人民医院2013年1月至2013年6月开展的＂金双歧去除肠道产ESBLs大肠埃希菌定植的临床研究＂科研项目中试验组患者102例,分成静脉使用抗菌药物组和未使用抗菌药物组,两组患者口服金双歧进行肠道内去定植。结果静脉使用抗菌药物组金双歧去除定植于肠道产ESBLs大肠埃希菌的去除率为30.30%;未使用抗菌药物组金双歧去除定植于肠道产ESBLs大肠埃希菌的去除率为41.67%。两组差异具有统计学意义（χ2=7.61,P〈0.01）。结论抗菌药物对金双歧具有抑制和杀灭作用,使金双歧去除定植于肠道的产ESBLs大肠埃希菌能力减弱或消失。     

地衣芽胞杆菌对白色念珠菌等的拮抗作用

目的了解地衣芽胞杆菌在试管内与阴道正常菌群共生关系的情况。方法将地衣芽胞杆菌菌液分别与葡萄球菌、大肠埃希菌、白色念珠菌、德氏乳杆菌混合培养,定量计数各菌在不同时间内单独培养和混合培养时各菌的活菌数。结果地衣芽胞杆菌生长不受金黄色葡萄球菌、白色念珠菌和大肠埃希菌的影响,金黄色葡萄球菌和白色念珠菌在有地衣芽胞杆菌存在的情况下,其生长受到明显的抑制（P〈0.05）;乳杆菌在12-48 h内,有显著的抑制地衣芽胞杆菌生长的作用,而乳杆菌的生长不受地衣芽胞杆菌的存在与否而正常生长。结论地衣芽胞杆菌对金黄色葡萄球菌及白色念珠菌在体外具有明显的拮抗作用,地衣芽胞杆菌对大肠埃希菌、乳杆菌无明显的体外拮抗作用。     

利用X-Neu5Ac为底物测定唾液酸酶活性在诊断细菌性阴道病的价值

目的利用5溴-4氯-3吲哚乙酰基神经氨酸盐（X-Neu5Ac）为底物测定阴道唾液酸酶活性诊断细菌性阴道病（bacterial vaginosis,BV）的价值.方法健康妇女30例,临床Amsel法诊断为BV的患者45例,共计75例进行了阴道分泌物分析和检测,并与唾液酸酶活性法诊断作了对比研究.取阴道分泌物作为标本分别进行唾液酸酶活性和阴道菌群定量分析,检测细菌包括乳酸杆菌、类杆菌、肠杆菌、葡萄球菌、肠球菌和阴道加德纳菌.唾液酸酶活性测定利用的底物为X-Neu5Ac,特异活性用其产物 ——甲氧基苯酚的纳摩尔数来表示.结果阴道液唾液酸酶活性测定诊断细菌性阴道病的敏感性、特异性、阳性预期值和阴性预期值分别为88.9%、90%、93%和84.3%.唾液酸酶法在检测细菌性阴道病上和传统的Amsel法比较,差异无显著性（P＞0.05）.唾液酸酶阳性组Gv活菌数（6.96 log CFU/g）明显高于唾液酸酶阴性组（2.05 log CFU/g）（P＜0.01）.唾液酸酶阳性组产H2O2阴道乳杆菌（LB＋）活菌数（4.26 Log CFU/g）明显低于唾液酸酶阴性组（8.66 Log CFU/g）（P＜0.01）.唾液酸酶阳性组与唾液酸酶阴性组两组的阴道液中需氧菌活菌数差异无显著性（P＞0.05）,主要包括金黄色葡萄球菌、肠球菌和肠杆菌.结论利用X-Neu5Ac作为唾液酸酶的底物测定唾液酸酶活性的方法是诊断细菌性阴道病的有效检测方法.阴道内唾液酸酶活性增强,厌氧菌数量增加,LB＋数量减少,提示BV发生恶化.     

乳酸杆菌细胞裂解物对金黄色葡萄球菌、大肠埃希菌的抑制作用

目的探讨乳杆菌DM8909裂解物在体内外对金黄色葡萄球菌、大肠埃希菌的抑制作用。方法通过对乳杆菌超声波破碎制成裂解物,分别用乳杆菌裂解物原液、裂解物稀释液、发酵上清液、乳杆菌活菌制剂进行体内、体外实验,观察乳杆菌各成分对金黄色葡萄球菌、大肠埃希菌的抑制作用。结果德氏乳酸杆菌裂解物对金黄色葡萄球菌、大肠埃希菌的抑制作用与乳杆菌活菌制剂的抑制作用相近。结论德氏乳酸杆菌裂解物在体内外对金黄色葡萄球菌、大肠埃希菌均有较强的抑制作用。     

Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells

AIMS: Lactobacilli, the predominant micro-organisms of the vaginal microbiota, play a major role in the maintenance of a healthy urogenital tract by preventing the colonization of pathogenic bacteria. The aim of the present study was to assess the ability of four vaginal Lactobacillus strains, previously selected for their probiotic features, to block in vitro the adherence of three human urogenital pathogens to vaginal epithelial cells (VEC). METHODS AND RESULTS: Three types of assays were performed in order to determine the inhibitory effect of lactobacilli on adhesion of urogenital pathogens to VEC: blockage by exclusion (lactobacilli and VEC followed by pathogens), competition (lactobacilli, VEC and pathogens together) and displacement (pathogens and VEC followed by the addition of lactobacilli). Bacterial adhesion to VEC was quantified by microscopy (x1000) after Gram's stain. All the strains were able to inhibit by exclusion and competition the adhesion of Staphylococcus aureus to VEC but none was able to decrease the attachment of Escherichia coli by neither of the mechanisms assayed. Only Lactobacillus acidophillus CRL 1259 and Lactobacillus paracasei CRL 1289 inhibited the attachment of Group B streptococci (GBS) to VEC by exclusion and competition respectively. CONCLUSIONS: Lactobacillus of vaginal origin were able to inhibit the attachment of genitouropathogenic Staph. aureus and GBS to the vaginal epithelium. SIGNIFICANCE AND IMPACT OF THE STUDY: The results support the probiotic potential of these Lactobacillus strains as anti-infective agents in the vagina and encourage further studies about their capacity to prevent and manage urogenital tract infections in females.     

甲硝唑与乳杆菌活菌制剂对细菌性阴道病患者阴道微生物群影响的对比性研究

目的对300例细菌性阴道病（Bacterial Vaginosis,BV）患者随机使用甲硝唑（100例）、乳杆菌活菌制剂定君生（100例）及甲硝唑联合定君生（100例）,观察乳杆菌在阴道内定植情况及用药前后阴道内微生物多样性的变化,为临床治疗细菌性阴道病提供实验依据。方法分别提取300例BV患者用药前和用药后的阴道微生物总基因组DNA,以德氏乳杆菌16SrDNA特异性引物进行PCR,检测患者用药后德氏乳杆菌在阴道内的定植情况。以细菌16SrRNAV3区通用引物进行PCR,扩增产物进行变性梯度凝胶电泳（DGGE）,对所得指纹图谱进行分析,研究用药对微生态变化的影响状况。结果甲硝唑治疗组用药前后均没有德氏乳杆菌检出;定君生治疗组用药后德氏乳杆菌检出率为54％;甲硝唑联合定君生治疗组用药后德氏乳杆菌检出率为76％。甲硝唑治疗组用药后微生物多样性显著降低,微生物群结构失衡;定君生治疗组用药后微生物多样性有所降低,微生物群结构无显著差异;甲硝唑联合定君生治疗组用药后微生物多样性降低,但较前两组有所增加,微生物群结构差异无统计学意义。结论甲硝唑显著降低BV患者阴道微生物多样性,引起微生态失衡;定君生对BV患者阴道微生态的影响明显小于甲硝唑;定君生的使用有利于甲硝唑f预后阴道微生物多样性的恢复和微生态平衡的重建。     

Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial

This study enrolled 125 premenopausal women diagnosed with bacterial vaginosis (BV) by presence of vaginal irritation, discharge and 'fishy' odor, and Nugent criteria and detection of sialidase enzyme. The subjects were treated with oral metronidazole (500 mg) twice daily from days 1 to 7, and randomized to receive oral Lactobacillus rhamnosus GR-1 (1 x 10(9)) and Lactobacillus reuteri RC-14 (1 x 10(9)) or placebo twice daily from days 1 to 30. Primary outcome was cure of BV as determined by normal Nugent score, negative sialidase test and no symptoms or signs of BV at day 30. A total of 106 subjects returned for 30-day follow-up, of which 88% were cured in the antibiotic/probiotic group compared to 40% in the antibiotic/placebo group (p<0.001). Of the remaining subjects, 30% subjects in the placebo group and none in the probiotic group had BV, while 30% in the placebo and 12% in the probiotic group fell into the intermediate category based upon Nugent score, sialidase result and clinical findings. High counts of Lactobacillus sp. (>10(5) CFU/ml) were recovered from the vagina of 96% probiotic-treated subjects compared to 53% controls at day 30. In summary, this study showed efficacious use of lactobacilli and antibiotic in the eradication of BV in black African women.     

Production of cytokines by vaginal epitheliocytes in the process of interaction with dominant and associative microsymbionts

AIM: Study the expression of cytokines by vaginal epitheliocytes in the process of interaction with dominant and associative microsymbionts. MATERIALS AND METHODS: IL-8, IL-6, IL-1beta and TNFalpha expression in response to interaction with heat inactivated Lactobacillus spp., Staphylococcus aureus, Escherichia coli, Corynebacterium spp. or their secretory products in comparison with basal expression of cytokines by vaginal epitheliocytes was studied. Results. Lactobacilli secretory products were shown not to influence the expression of IL-8 and IL-1beta and moderately stimulated IL-6 and TNFalpha expression. Contact of epitheliocytes with heat inactivated lactobacilli increased secretion of IL-8, IL-6 and IL-1beta and reduced TNFalpha production. Secretory products of S. aureus and E. coli caused stimulation of IL-6, IL-1beta production and practically did not change the expression of IL-8 and TNFalpha. Contact of epitheliocytes with heat inactivated S. aureus sup pressed TNFalpha production and had no influence on IL-8, IL-6 and IL-1beta expression, contact with E. colistimulated TNFalpha and IL-1beta expression and suppressed IL-6 expression. Changes in cytokine expression during interaction of epitheliocytes with corynebacteria were largely similar to the results of interaction with lactobacilli except IL-6 production that was markedly stimulated by corynebacteria secretory products. Conclusion. In epithelial-bacterial interactions dominant and associative microorganisms have a differential effect on functional status of mucosal epitheliocytes manifesting in production of cytokines that could be the basis of mucosal immunity regulation.     

Dynamics of vaginal bacterial communities in women developing bacterial vaginosis, candidiasis, or no infection, analyzed by PCR-denaturing gradient gel electrophoresis and real-time PCR

The microbial flora of the vagina plays a major role in preventing genital infections, including bacterial vaginosis (BV) and candidiasis (CA). An integrated approach based on PCR-denaturing gradient gel electrophoresis (PCR-DGGE) and real-time PCR was used to study the structure and dynamics of bacterial communities in vaginal fluids of healthy women and patients developing BV and CA. Universal eubacterial primers and Lactobacillus genus-specific primers, both targeted at 16S rRNA genes, were used in DGGE and real-time PCR analysis, respectively. The DGGE profiles revealed that the vaginal flora was dominated by Lactobacillus species under healthy conditions, whereas several potentially pathogenic bacteria were present in the flora of women with BV. Lactobacilli were the predominant bacterial population in the vagina for patients affected by CA, but changes in the composition of Lactobacillus species were observed. Real-time PCR analysis allowed the quantitative estimation of variations in lactobacilli associated with BV and CA diseases. A statistically significant decrease in the relative abundance of lactobacilli was found in vaginal fluids of patients with BV compared to the relative abundance of lactobacilli in the vaginal fluids of healthy women and patients with CA.